My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 645

    1.

    Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2 years.

    van der Heijde D, Salonen D, Weissman BN, Landewé R, Maksymowych WP, Kupper H, Ballal S, Gibson E, Wong R; Canadian (M03-606) study group; ATLAS study group.

    Arthritis Res Ther. 2009;11(4):R127. Epub 2009 Aug 24.PMID: 19703304 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis.

    van der Heijde D, Landewé R, Baraliakos X, Houben H, van Tubergen A, Williamson P, Xu W, Baker D, Goldstein N, Braun J; Ankylosing Spondylitis Study for the Evaluation of Recombinant Infliximab Therapy Study Group.

    Arthritis Rheum. 2008 Oct;58(10):3063-70.PMID: 18821688 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Radiographic progression in patients with ankylosing spondylitis after 4 yrs of treatment with the anti-TNF-alpha antibody infliximab.

    Baraliakos X, Listing J, Brandt J, Haibel H, Rudwaleit M, Sieper J, Braun J.

    Rheumatology (Oxford). 2007 Sep;46(9):1450-3. Epub 2007 Jul 10.PMID: 17623745 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanercept.

    van der Heijde D, Landewé R, Einstein S, Ory P, Vosse D, Ni L, Lin SL, Tsuji W, Davis JC Jr.

    Arthritis Rheum. 2008 May;58(5):1324-31.PMID: 18438853 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Radiographic progression in patients with ankylosing spondylitis after 2 years of treatment with the tumour necrosis factor alpha antibody infliximab.

    Baraliakos X, Listing J, Rudwaleit M, Brandt J, Sieper J, Braun J.

    Ann Rheum Dis. 2005 Oct;64(10):1462-6. Epub 2005 Mar 18.PMID: 15778240 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Adalimumab significantly reduces both spinal and sacroiliac joint inflammation in patients with ankylosing spondylitis: a multicenter, randomized, double-blind, placebo-controlled study.

    Lambert RG, Salonen D, Rahman P, Inman RD, Wong RL, Einstein SG, Thomson GT, Beaulieu A, Choquette D, Maksymowych WP.

    Arthritis Rheum. 2007 Dec;56(12):4005-14.PMID: 18050198 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Physical function, disease activity, and health-related quality-of-life outcomes after 3 years of adalimumab treatment in patients with ankylosing spondylitis.

    van der Heijde DM, Revicki DA, Gooch KL, Wong RL, Kupper H, Harnam N, Thompson C, Sieper J; ATLAS Study Group.

    Arthritis Res Ther. 2009;11(4):R124. Epub 2009 Aug 17.PMID: 19686597 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Adalimumab effectiveness for the treatment of ankylosing spondylitis is maintained for up to 2 years: long-term results from the ATLAS trial.

    van der Heijde D, Schiff MH, Sieper J, Kivitz AJ, Wong RL, Kupper H, Dijkmans BA, Mease PJ, Davis JC Jr; ATLAS Study Group.

    Ann Rheum Dis. 2009 Jun;68(6):922-9. Epub 2008 Aug 13.PMID: 18701556 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    The natural course of radiographic progression in ankylosing spondylitis--evidence for major individual variations in a large proportion of patients.

    Baraliakos X, Listing J, von der Recke A, Braun J.

    J Rheumatol. 2009 May;36(5):997-1002. Epub 2009 Mar 30.PMID: 19332632 [PubMed - indexed for MEDLINE]Related articles

    10.

    Adalimumab reduces pain, fatigue, and stiffness in patients with ankylosing spondylitis: results from the adalimumab trial evaluating long-term safety and efficacy for ankylosing spondylitis (ATLAS).

    Revicki DA, Luo MP, Wordsworth P, Wong RL, Chen N, Davis JC Jr; ATLAS Study Group.

    J Rheumatol. 2008 Jul;35(7):1346-53. Epub 2008 May 15.PMID: 18484692 [PubMed - indexed for MEDLINE]Related articles

    11.

    Etanercept in the longterm treatment of patients with ankylosing spondylitis.

    Dijkmans B, Emery P, Hakala M, Leirisalo-Repo M, Mola EM, Paolozzi L, Salvarani C, Sanmarti R, Sibilia J, Sieper J, Van Den Bosch F, van der Heijde D, van der Linden S, Wajdula J.

    J Rheumatol. 2009 Jun;36(6):1256-64. Epub 2009 May 1.PMID: 19411393 [PubMed - indexed for MEDLINE]Related articles

    12.

    Physical function in ankylosing spondylitis is independently determined by both disease activity and radiographic damage of the spine.

    Landewé R, Dougados M, Mielants H, van der Tempel H, van der Heijde D.

    Ann Rheum Dis. 2009 Jun;68(6):863-7. Epub 2008 Jul 15.PMID: 18628283 [PubMed - indexed for MEDLINE]Related articles

    13.

    Cost effectiveness of adalimumab for the treatment of ankylosing spondylitis in the United Kingdom.

    Botteman MF, Hay JW, Luo MP, Curry AS, Wong RL, van Hout BA.

    Rheumatology (Oxford). 2007 Aug;46(8):1320-8. Epub 2007 Jun 2.PMID: 17545684 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Health-related quality of life outcomes in patients with active ankylosing spondylitis treated with adalimumab: results from a randomized controlled study.

    Davis JC Jr, Revicki D, van der Heijde DM, Rentz AM, Wong RL, Kupper H, Luo MP.

    Arthritis Rheum. 2007 Aug 15;57(6):1050-7.PMID: 17665483 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Adalimumab for long-term treatment of psoriatic arthritis: forty-eight week data from the adalimumab effectiveness in psoriatic arthritis trial.

    Gladman DD, Mease PJ, Ritchlin CT, Choy EH, Sharp JT, Ory PA, Perdok RJ, Sasso EH.

    Arthritis Rheum. 2007 Feb;56(2):476-88.PMID: 17265483 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Adalimumab effectively reduces the signs and symptoms of active ankylosing spondylitis in patients with total spinal ankylosis.

    van der Heijde D, Pangan AL, Schiff MH, Braun J, Borofsky M, Torre J, Davis JC Jr, Wong RL, Kupper H, Collantes E; ATLAS Study Group.

    Ann Rheum Dis. 2008 Sep;67(9):1218-21. Epub 2007 Dec 4.PMID: 18056755 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial.

    Wanders A, Heijde D, Landewé R, Béhier JM, Calin A, Olivieri I, Zeidler H, Dougados M.

    Arthritis Rheum. 2005 Jun;52(6):1756-65.PMID: 15934081 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Radiological scoring methods for ankylosing spondylitis: a comparison between the Bath Ankylosing Spondylitis Radiology Index and the modified Stoke Ankylosing Spondylitis Spine Score.

    Salaffi F, Carotti M, Garofalo G, Giuseppetti GM, Grassi W.

    Clin Exp Rheumatol. 2007 Jan-Feb;25(1):67-74.PMID: 17417993 [PubMed - indexed for MEDLINE]Related articles

    19.

    Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial.

    van der Heijde D, Kivitz A, Schiff MH, Sieper J, Dijkmans BA, Braun J, Dougados M, Reveille JD, Wong RL, Kupper H, Davis JC Jr; ATLAS Study Group.

    Arthritis Rheum. 2006 Jul;54(7):2136-46.PMID: 16802350 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Serum matrix metalloproteinase 3 is an independent predictor of structural damage progression in patients with ankylosing spondylitis.

    Maksymowych WP, Landewé R, Conner-Spady B, Dougados M, Mielants H, van der Tempel H, Poole AR, Wang N, van der Heijde D.

    Arthritis Rheum. 2007 Jun;56(6):1846-53.PMID: 17530713 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Write to the Help Desk